We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
146 hedge funds and large institutions have $71M invested in Fate Therapeutics in 2025 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 54 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
24% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 17
2% more funds holding
Funds holding: 143 → 146 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7.31% less ownership
Funds ownership: 69.87% → 62.56% (-7.3%)
30% less capital invested
Capital invested by funds: $102M → $71M (-$30.6M)
43% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 54
43% less call options, than puts
Call options by funds: $70K | Put options by funds: $122K
Holders
146
Holders Change
+3
Holders Change %
+2.1%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
21
Increased
31
Reduced
54
Closed
17
Calls
$70K
Puts
$122K
Net Calls
-$52K
Net Calls Change
-$115K
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.83M |
| 2 |
Renaissance Technologies
New York
|
+$1.32M |
| 3 |
Two Sigma Investments
New York
|
+$1M |
| 4 |
Two Sigma Advisers
New York
|
+$774K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$660K |
